NHS Neuberger Berman Group Earnings per share growth this year

Official company branding of Neuberger Berman Group (NHS)

The fund benefits from leveraged capital in bonds, with borrowing costs already priced in. The annual EPS range on the GURU.Markets daily chart shows that the 0.00 mark remains a relevant indicator as Neuberger Berman High Yield Fund (NHS) develops credit strategies with institutional investors. Efficiency is increasing through the implementation of AI systems that automate compliance and analytics.

Net earnings per share growth this year: Neuberger Berman High Yield Strategies Fund (NHS) for 07/04/2022 - 10/17/2026

Financial and market metric breakdowns for Neuberger Berman (NHS)

- current quotes and average value forecast:
Market Chart Neuberger Berman High Yield|NHS - Price Target Chart
- market capitalization data:
Market Capitalization Neuberger Berman Group|NHS - Enterprise Value
- book capitalization information:
Net Asset Value per Share Neuberger Berman|NHS - Company Net Assets|Market Capitalization to Book Value Ratio nb.com|NHS - Company Total Assets
- debt burden and liquidity indicators:
Debt to Equity Neuberger Berman|NHS - Long-Term Debt to Capital|Current Liabilities to Capital nb.com|NHS - Company Debts|Debt to Net Assets Ratio Neuberger Berman Group|NHS - Company Long-Term Debts|Short-Term Indebtedness Neuberger Berman|Immediate Liquidity nb.com
- company profitability and valuation multiples indicators:
NHS - Company Net Income|Expected Net Income Neuberger Berman|NHS - Price to Earnings Ratio|Future Price to Earnings Multiple Neuberger Berman Group|NHS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuberger Berman Group|NHS - Operating profit EBITDA|Net earnings per one share for the last twelve months Neuberger Berman|NHS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months nb.com|NHS - Earnings per share growth in current year|Expected earnings per share growth for next year Neuberger Berman
Basic company analysis:Neuberger Berman High Yield (NHS)
Finished products of Neuberger Berman Fund

The efficiency of Neuberger Berman (NHS) credit analysis for high-yield bonds converts directly into operating profit, determining the fund's attractiveness to retail capital. This indicator measures the annual change in net income per share, reflecting the growth rate of real shareholder income, which allows for an assessment of fundamental business stability through YoY net income per share dynamics.

Direct competitors

FSCO - Expected net earnings per share growth this year|Earnings per share growth in current year Cohen & Steers PTA|Earnings per share growth this year RA (Brookfield RA Fund)|Earnings growth in current year PAXS|NPFD - Earnings per share growth rate in current year|Highland Income Fund - Net earnings per share growth this year|Earnings growth in current year Ares Dynamic Credit Allocation Fund, Inc. ARDC|EIC Fund - Earnings growth in current year|BRW: Earnings per share growth in current year|JGH: Earnings growth in current year|Earnings per share growth rate in current year nuveen.com (NPCT)|Earnings per share growth in current year Western Asset High Yield Defined Opportunity Fund Inc.|FTF: Earnings per share increase in current year|Earnings growth in current year OPP|Pioneer High Income (HNW) - Net earnings per share change in current year|Earnings growth in current year GDO (Western Asset Global High Income Fund)|principalcef.com (PGZ) - Earnings per share growth rate in current year|JMM - Earnings per share growth in current year|Earnings per share increase in current year CBH (Virtus Convertible and Income Fund)|INSI (cutwater.com) - Net earnings per share growth this year|Invesco High Income Fund - Earnings per share increase in current year